Sermorelin may interfere with blood glucose control and reduce the effectiveness of metformin and other diabetic medications
Vitamin B12 deficiency is pretty common, and many people take B12 injections
GLP-1 receptor agonists (GLP-1 RA) medications can reduce the number of deaths, amputations and hospitalisations among patients with peripheral arterial disease (PAD) and type 2 diabetes, according to new, independent research published in the Journal of the American Heart Association ( JAHA )
Phillipe OBrien was an employee of Eli Lilly and Company at the time of submission
People with serious gastrointestinal conditions, like gastroparesis or uncontrolled inflammatory bowel disease, should not take GLP-1 medications
While BPC 157 has demonstrated great potential in treating many medical conditions, its important to note that more research still needs to be done before it can be considered an approved treatment option